JDD Issue Highlights | December 2021
JDDAs 2021 draws to a close, the  Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everyt …
JDD
Test Your Knowledge of Hyperhidrosis and Sweat!
hyperhidrosis and sweatIn support of Hyperhidrosis Awareness , let's test your knowledge of Hyperhidrosis and Sweat with a few quizzes! If a person has the medical condition of hyperhidrosis (excessive sweating), their risk of skin infections increases by how much? A. 100% B. 200% C. 300% D. 0% Correct Answer: view here. ___________________________________________________________________ …
hyperhidrosis and sweat
Advocating for Diversity, Equity, and Inclusion in Dermatology and LGBTQ Health
LGBTQAt the 2021 Skin of Color Update, Dr. Andrew Alexis hosted a panel discussion on Diversity, Equity, and Inclusion (DEI), with dermatology powerhouses Dr. Susan Taylor and Dr. Klint Peebles. These two panelists have tirelessly advocated for their respective causes, advancement of knowledge within skin of color (SOC) and LGBTQ (lesbian, gay, bisexual transgender, queer) health. Our first panelist …
LGBTQ
Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar PustulosisPalmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
Palmoplantar Pustulosis
Thalidomide for Dermatologic Conditions | Therapeutic Cheat Sheet
ThalidomideThalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We …
Thalidomide